Bibliography
- Impact. Innovation. Predictability. Access. 2012 Novel New Drugs. Center for Drug Evaluation and Research, Food and Drug Administration. USA; 2013. Available from: http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/DrugInnovation/ucm293663.pdf [Accessed 1 May 2014]
- Lanthier M, Miller KL, Nardinelli C, Woodcock J. An improved approach to measuring drug innovation finds steady rates of first-in-class pharmaceuticals, 1987-2011. Health Aff 2013;32:1433-9
- Impact. Innovation. Predictability. Access. 2013 Novel New Drugs. Center for Drug Evaluation and Research, Food and Drug Administration; USA; 2014.
- Sadinowski FJ. Quantum effectiveness evidence in FDA’s approval of orphan drugs. Drug Inf J 2012;46:238-63
- European Medicines Agency. Bosulif. 2013. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002373/human_med_001613.jsp&mid=WC0b01ac058001d124 [Accessed 1 May 2014]
- Pfizer. Highlights of prescribing information. 2013. Available from: http://labeling.pfizer.com/ShowLabeling.aspx?id=884 [Accessed 1 May 2014]
- Food and Drug Administration. FDA approves Cometriq to treat rare type of thyroid cancer. 2012. Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm330143.htm [Accessed 1 May 2014]
- European Medicines Agency. Cometriq. 2013. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002640/smops/Positive/human_smop_000623.jsp&mid=WC0b01ac058001d127 [Accessed 1 May 2014]
- Food and Drug Administration. FDA approves new orphan drug to treat a form of Gaucher disease. 2012. Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm302549.htm [Accessed 1 May 2014]
- van Dussen L, Zimran A, Akkeman EM, et al. Taliglucerase alfa leads to favorable bone marrow responses in patients with type I Gaucher disease. Blood Cells Mol Dis 2013;50:206-11
- Jeppesen PB. Teduglutide, a novel glucagon-like peptide 2 analog, in the treatment of patients with short bowel syndrome. Therap Adv Gastroenterol 2012;5:159-71
- Food and Drug Administration. FDA approves Iclusig to treat two rare types of leukemia. 2012. Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm332252.htm [Accessed 1 May 2014]
- Food and Drug Administration. FDA approves new orphan drug for rare cholesterol disorder. 2012. Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm333285.htm [Accessed 1 May 2014]
- European Medicines Agency. Lojuxta. 2013. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002578/human_med_001668.jsp&mid=WC0b01ac058001d124 [Accessed 1 May 2014]
- Food and Drug Administration. FDA approves Kalydeco to treat a rare form of cystic fibrosis. 2012. Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm289633.htm [Accessed 1 May 2014]
- European Medicines Agency. Kalydeco. 2013. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002494/human_med_001575.jsp&mid=WC0b01ac058001d124 [Accessed 1 May 2014]
- Food and Drug Administration. FDA approves Kyprolis for some patients with multiple myeloma. 2012. Available from: http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm312920.htm [Accessed 1 May 2014]
- European Medicines Agency. EU/3/08/548. 2013. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/orphans/2009/11/human_orphan_000407.jsp&mid=WC0b01ac058001d12b [Accessed 1 May 2014]
- Food and Drug Administration. FDA approves raxibacumab to treat inhalational anthrax. 2012. Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm332341.htm [Accessed 1 May 2014]
- Food and Drug Administration. FDA approves Signifor, a new orphan drug for Cushing’s disease. 2012. Available from: http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm332351.htm [Accessed 1 May 2014]
- European Medicines Agency. Signifor. 2013. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002052/human_med_001547.jsp&mid=WC0b01ac058001d124 [Accessed 1 May 2014]
- Food and Drug Administration. FDA approves Synribo for chronic myelogenous leukemia. 2012. Available from: http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm325895.htm [Accessed 1 May 2014]
- European Medicines Agency. Tekinex. 2011. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/001244/wapp/Initial_authorisation/human_wapp_000112.jsp&mid=WC0b01ac058001d128 [Accessed 1 May 2014]
- Food and Drug Administration. FDA approves Voraxaze to treat patients with toxic methotrexate levels. 2012. Available from: http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm287997.htm [Accessed 1 May 2014]
- European Medicines Agency. Voraxaze. 2008. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000681/wapp/Initial_authorisation/human_wapp_000069.jsp&mid=WC0b01ac058001d128 [Accessed 1 May 2014]
- European Medicines Agency. Adempas. 2014. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002737/smops/Positive/human_smop_000640.jsp&mid=WC0b01ac058001d127 [Accessed 1 May 2014]
- European Medicines Agency. EU/3/12/1054. 2012. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/orphans/2012/11/human_orphan_001129.jsp&mid=WC0b01ac058001d12b [Accessed 1 May 2014]
- Food and Drug Administration. FDA approves new treatment for a type of late-stage lung cancer. 2013. Available from: http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm360499.htm [Accessed 1 May 2014]
- European Medicines Agency. Giotrif. 2013. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002280/human_med_001698.jsp&mid=WC0b01ac058001d124 [Accessed 1 May 2014]
- European Medicines Agency. EU/3/13/1203. 2013. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/orphans/2013/12/human_orphan_001282.jsp&mid=WC0b01ac058001d12b [Accessed 1 May 2014]
- European Medicines Agency. Kynamro. 2012. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002429/smops/Negative/human_smop_000460.jsp&mid=WC0b01ac058001d127 [Accessed 1 May 2014]
- Food and Drug Administration. FDA approves two drugs, companion diagnostic test for advanced skin cancer. 2013. Available from: http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm354199.htm [Accessed 1 May 2014]
- Wright CJ, McCormack PL. Trametinib: first global approval. Drugs 2013;73:1245-54